Skip to content
healthcare.dev
Get a free key

ZYNYZ

NDC 50881-006, retifanlimab-dlwr, injection, from Incyte Corporation.

Product NDC
50881-006
Status
Listed
Labeler
Incyte Corporation
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761334
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50881-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RETIFANLIMAB25 mg/mL

Pharmacologic classes

Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
50881-006-03508810006031 VIAL, SINGLE-USE in 1 CARTON (50881-006-03) / 20 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/109648d0-d30a-42fc-8273-39cb1540a751

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50881-006

Use it

Look up 50881-006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50881-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50881-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.